U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07543120) titled 'An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.' on April 15.
Brief Summary: The purpose of this extension study is to collect additional safety and efficacy on QCZ484 for hypertensive patients who successfully completed the parent study, CQCZ484A12201 or additional QCZ484 studies as specified in the respective parent study protocols.
Study Start Date: May 01
Study Type: INTERVENTIONAL
Condition:
Hypertension (HTN)
Intervention:
DRUG: QCZ484
QCZ484 subcutaneous injection, Q6M.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Novartis Pharmaceuticals
Published by HT Digital Content Serv...